MedTrace Logo

Smoking Cessation in Hispanic Construction Workers

NCT02873377 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2019-11-07

Study results available
· View outcomes & findings →

Summary

Construction workers have the highest rate of smoking among all occupations, and are frequently exposed to a wide range of workplace hazards (e.g. toxins), which interact with smoking to increase their health risks. Minority construction workers, in particular, have higher smoking and lower cessation rates compared to other groups, and they generally show lower access and participation in cessation and health promotion services. The number of Hispanic workers employed in the construction industry in the US has tripled in the past decade to 2.6 million (23% of all construction workers). This study will develop, administer, and evaluate a novel smoking cessation program in a hard-to-reach and underserved population of Hispanic male construction workers using using pilot cluster randomized clinical trial (RCT) to test the developed intervention for feasibility and potential efficacy.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicorette Gum

GlaxoSmithKline Nicorette Gum (nicotine replacement therapy)

DRUG

Nicoderm CQ

GlaxoSmithKline Nicoderm CQ (nicotine replacement therapy)

OTHER

Smoking Quitline Referral

Fax referral to the State smoking Quitline

BEHAVIORAL

Behavioral Smoking Cessation Counseling

One time face-to-face smoking cessation counseling and follow-up phone call

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Miami

    lead OTHER

Principal Investigators

  • David J Lee, PhD · University of Miami

  • Taghrid Asfar, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-13
Primary Completion
2018-10-11
Completion
2018-10-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873377 on ClinicalTrials.gov